Company / Financials
Renalytix plc Financials
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.3M
FY2024 · -32.7% YoY
Net Income
-$33.5M
FY2024 · +26.6% YoY
Profit Margin
-1461.6%
FY2024 · net income / revenue
ROE
-
FY2024 · return on equity
Total Assets
$8.0M
FY2024
Total Debt
-
FY2024
Equity
-$7.9M
FY2024
ROA
-419.7%
FY2024 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -34.45 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.3M-32.7% YoYNet Income HistoryProfit after all expenses and taxes-$33.5M+26.6% YoYGross Profit HistoryRevenue minus cost of goods sold$156.0K-78.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$2.1M-20.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$29.6M+29.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$19.8M-31.1% YoYR&D Expense HistoryResearch and development spending$9.3M-35.0% YoYIncome Tax HistoryTotal income tax expense$4.0K+100.0% YoYEPS (Basic) HistoryBasic earnings per share-$0.55+11.3% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.55+17.9% YoY